CN116075295A - 新型可注射油基药物组合物 - Google Patents

新型可注射油基药物组合物 Download PDF

Info

Publication number
CN116075295A
CN116075295A CN202180041014.6A CN202180041014A CN116075295A CN 116075295 A CN116075295 A CN 116075295A CN 202180041014 A CN202180041014 A CN 202180041014A CN 116075295 A CN116075295 A CN 116075295A
Authority
CN
China
Prior art keywords
agents
formulation
particles
core
coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180041014.6A
Other languages
English (en)
Chinese (zh)
Inventor
A·乔纳森
M·鲁斯
J·海尔拉普
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CANDIX AB
Original Assignee
CANDIX AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CANDIX AB filed Critical CANDIX AB
Publication of CN116075295A publication Critical patent/CN116075295A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN202180041014.6A 2020-04-17 2021-04-16 新型可注射油基药物组合物 Pending CN116075295A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2005593.5 2020-04-17
GBGB2005593.5A GB202005593D0 (en) 2020-04-17 2020-04-17 New composition
PCT/GB2021/050913 WO2021209762A1 (en) 2020-04-17 2021-04-16 Injectable oil-based pharmaceutical composition

Publications (1)

Publication Number Publication Date
CN116075295A true CN116075295A (zh) 2023-05-05

Family

ID=70860026

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180041014.6A Pending CN116075295A (zh) 2020-04-17 2021-04-16 新型可注射油基药物组合物

Country Status (9)

Country Link
US (1) US20230157968A1 (https=)
EP (1) EP4135672A1 (https=)
JP (1) JP2023522056A (https=)
KR (1) KR20230004568A (https=)
CN (1) CN116075295A (https=)
AU (1) AU2021256075A1 (https=)
CA (1) CA3179556A1 (https=)
GB (1) GB202005593D0 (https=)
WO (1) WO2021209762A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117844877A (zh) * 2024-01-14 2024-04-09 宿州市东凯医药科技有限公司 一种通过生物酶制备普瑞巴林的方法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024546476A (ja) * 2021-12-08 2024-12-24 ナネクサ・アクチボラグ 新たな注射用併用製剤
GB2619556A (en) * 2022-06-10 2023-12-13 Nanexa Ab New process
JP2026500290A (ja) * 2022-12-15 2026-01-06 ナネクサ・アクチボラグ グルカゴン様ペプチド－１受容体アゴニストを含む新規医薬組成物
GB202218958D0 (en) 2022-12-15 2023-02-01 Nanexa Ab New pharmaceutical composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006080895A1 (en) 2005-01-20 2006-08-03 Agency For Science, Technology And Research Water-soluble, surface-functionalized nanoparticle for bioconjugation via universal silane coupling
SI2341905T2 (sl) * 2008-09-04 2024-02-29 Amylin Pharmaceuticals, Llc Formulacije s podaljšanim sproščanjem z uporabo brezvodnih nosilcev
PL3003286T3 (pl) * 2013-05-24 2022-10-10 Nanexa Ab Sposób wytwarzania stałych nanocząstek z nieorganiczną powłoką i ich zastosowanie

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117844877A (zh) * 2024-01-14 2024-04-09 宿州市东凯医药科技有限公司 一种通过生物酶制备普瑞巴林的方法

Also Published As

Publication number Publication date
WO2021209762A1 (en) 2021-10-21
EP4135672A1 (en) 2023-02-22
JP2023522056A (ja) 2023-05-26
CA3179556A1 (en) 2021-10-21
AU2021256075A1 (en) 2022-11-03
KR20230004568A (ko) 2023-01-06
US20230157968A1 (en) 2023-05-25
GB202005593D0 (en) 2020-06-03

Similar Documents

Publication Publication Date Title
US11214865B2 (en) Apparatus for coating particles
CN116075295A (zh) 新型可注射油基药物组合物
JP7733651B2 (ja) 新規組成物
JP7828278B2 (ja) 医薬組成物の製造のための新規プロセス
US20250041208A1 (en) New injectable combination formulation
KR20250022795A (ko) 약학적 조성물의 제조를 위한 기상 증착 기술
GB2594083A (en) New composition
US20240261228A1 (en) New process
CN118647367A (zh) 新颖可注射组合制剂

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination